Public Release: 

SNM experts focus on advances in molecular imaging for cancer, addiction, Alzheimer's, heart disease

Two-day mid-winter educational symposium explores medical imaging Feb. 11-12 in Tempe, Ariz.

Society of Nuclear Medicine

Leading medical investigators will present recent developments in the diagnosis of cancer and heart and brain diseases during the Society of Nuclear Medicine's Mid-Winter Educational Symposium Feb. 11-12 at Wyndham Buttes in Tempe, Ariz.

Noted physicians, scientists and technologists will present the latest news about using nuclear medicine and molecular imaging for the diagnosis, management and treatment of diseases to several hundred nuclear medicine physicians, radiologists, cardiologists, oncologists, technologists, pharmacists, medical physicists and other health care professionals. SNM is the largest scientific organization dedicated to nuclear medicine and molecular imaging, with more than 16,000 members. This year's topics include new molecular imaging agents for oncology, new developments in Alzheimer's disease and addiction, an overview of congestive heart failure and nuclear imaging, imaging atherosclerosis and stem cells, radiation safety, potential future clinical tracers, an introduction to cell and molecular biology, small animal imaging instrumentation and the evolving role of a nuclear medicine technologist.

"The society offers an exciting two-day program in Tempe exploring the development of novel probes in molecular imaging, monitoring treatment response with positron emission tomography, radiotracer imaging in congestive heart failure, advanced image processing and clinical nuclear medicine technology," said SNM President Peter S. Conti, M.D., Ph.D., professor of radiology, clinical pharmacy and biomedical engineering at the University of Southern California, Los Angeles. "In addition, the evolving role of nuclear medicine technologists will be examined," added SNM Technologist Section (SNMTS) President Valerie R. Cronin, CNMT, FSNMTS, director of imaging services at the Catholic Health System of Western New York in Buffalo, N.Y.


For more information or to register, visit SNM's Web site:

About the Society of Nuclear Medicine
The Society of Nuclear Medicine is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of nuclear medicine and molecular imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances; provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed resource in the field of nuclear and molecular imaging: The Journal of Nuclear Medicine; sponsor research grants, fellowships and awards; and host the premier nuclear medicine annual meeting. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.